New Collaboration with SciClix

New Collaboration with SciClix

Published on 12/08/2020

Find out more about our partner SciClix from Singapore and our new collaboration!
New Collaboration with SciClix

Iris Biotech is pleased to announce our distributorship agreement with the Singapore-based company SciClix Pte. Ltd., a spinoff from the “Institute of Chemical & Engineering Sciences (ICES), Agency for Science, Technology & Research” (A*STAR). SciClix is focused on the design, synthesis, and supply of non-traditional molecular motifs; while also developing specific applications of novel-motif based small molecules, peptides, and polymers. Using our global network, Iris Biotech has been marketing SciClix’s innovative building blocks for more than one year.

Building on this fruitful collaboration, SciClix and Iris Biotech decided to enter into a distributorship agreement, elevating our partnership to the next level. As of 23 July 2020, SciClix acts as sole and exclusive distributor for the whole product portfolio of Iris Biotech in the ASEAN region. Our agreement encompasses the following countries: Singapore, Thailand, Malaysia, Indonesia, Vietnam, the Philippines, Brunei, Burma (Myanmar), Laos, Cambodia, and Timor-Leste.

➔ Curious about the innovative products developed and manufactured by SciClix? Visit our webshop section about Bicyclic Amino Acids!

➔ Contact SciClix at:

SciClix Pte. Ltd.

Level 8 The Metropolis Tower 2,

11 N Buona Vista Dr

Singapore 138589 SINGAPORE

Phone: +65 6808 7854

Email: orders@sciclix.com

Internet: www.sciclix.com